Anixa Biosciences (ANIX) News Today → Warning: this could blow your mind (From DTI) (Ad) Free ANIX Stock Alerts $3.12 -0.11 (-3.41%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnixa Biosciences, Inc. to Post Q2 2024 Earnings of ($0.11) Per Share, HC Wainwright Forecasts (NASDAQ:ANIX)americanbankingnews.com - March 25 at 1:40 AMAnixa Biosciences, Inc. Forecasted to Earn Q1 2025 Earnings of ($0.11) Per Share (NASDAQ:ANIX)americanbankingnews.com - March 23 at 3:54 AMAnixa Biosciences, Inc. (NASDAQ:ANIX) to Post Q1 2025 Earnings of ($0.11) Per Share, HC Wainwright Forecastsmarketbeat.com - March 22 at 8:35 AMAnixa Biosciences (NASDAQ:ANIX) Receives Buy Rating from HC Wainwrightamericanbankingnews.com - March 22 at 5:32 AMAnixa Biosciences' (ANIX) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 21 at 8:20 AMAnixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Up 8.2% in Februarymarketbeat.com - March 18 at 12:48 AMANIX Apr 2024 7.500 callfinance.yahoo.com - March 16 at 6:10 PMANIX Apr 2024 2.500 putfinance.yahoo.com - March 16 at 6:10 PMAnixa Biosciences, Inc. (NASDAQ:ANIX) Director Buys $36,300.00 in Stockinsidertrades.com - March 16 at 10:59 AMAnixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases $36,300.00 in Stockmarketbeat.com - March 15 at 4:48 PMAnixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Partiesprnewswire.com - March 14 at 8:45 AMRecap: Anixa Biosciences Q1 Earningsbenzinga.com - March 12 at 6:24 PMAnixa Biosciences Announces Presentation at 24th Annual World Vaccine Congressprnewswire.com - March 11 at 8:00 AMAnixa Biosciences Stock (NASDAQ:ANIX) Insider Tradesbenzinga.com - February 22 at 12:54 PMAnixa Biosciences Inc (ANIX)investing.com - February 21 at 12:48 PMWe Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growthfinance.yahoo.com - February 17 at 9:45 AMANIX Feb 2024 5.000 callfinance.yahoo.com - February 17 at 12:11 AMAnixa Biosciences, Inc. Expected to Post FY2025 Earnings of ($0.40) Per Share (NASDAQ:ANIX)marketbeat.com - February 15 at 8:44 AMAnalysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)markets.businessinsider.com - February 13 at 6:48 PMAnixa Biosciences (NASDAQ:ANIX) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - February 13 at 1:34 PMAnixa Biosciences, Inc.: Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trialfinanznachrichten.de - February 12 at 12:42 PMAnixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trialfinance.yahoo.com - February 12 at 7:42 AM3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023finance.yahoo.com - February 6 at 3:38 PMDogs Can Suffer from Depression — Here Are Signs to Look Out for and How to Diagnosis Themca.finance.yahoo.com - January 30 at 10:38 PMHere’s Why You Get a Runny Nose When You’re Eatingmsn.com - January 30 at 10:38 PMVisible wants to track your illness, more than your fitnessca.news.yahoo.com - January 30 at 10:38 PMRecalled cinnamon applesauce pouches were never tested for lead, FDA reportsca.finance.yahoo.com - January 30 at 10:38 PMIf You Suffer From Intense PMS, This Condition Could Be The Causeca.style.yahoo.com - January 30 at 10:38 PMKing Charles smiles as he leaves hospital following prostate procedureca.style.yahoo.com - January 30 at 10:38 PMKristen Dahlgren: Why I’m leaving NBC to launch a nonprofit to make breast cancer vaccines a realitymsn.com - January 30 at 10:38 PMAnixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Up 10.7% in Januarymarketbeat.com - January 29 at 12:48 PMAnixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conferencefinance.yahoo.com - January 29 at 9:28 AMAnixa ovarian cancer vaccine tech gets Japanese patentmsn.com - January 23 at 2:09 PMAnixa Biosciences, Inc.: Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technologyfinanznachrichten.de - January 23 at 9:09 AMAnixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technologyfinance.yahoo.com - January 23 at 9:09 AMAnixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024finance.yahoo.com - January 10 at 9:55 AMMission Wealth Management LP Invests $1.64 Million in Anixa Biosciences, Inc. (NASDAQ:ANIX)marketbeat.com - January 2 at 8:15 AMAnixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Up 14.2% in Decembermarketbeat.com - January 1 at 5:54 AMAnixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?benzinga.com - December 20 at 6:20 PMBreast cancer vaccine could prevent most aggressive form of disease from reoccurringmsn.com - December 18 at 10:35 PMBreast cancer vaccine present positive datamsn.com - December 14 at 12:14 PMAnixa Biosciences to Present at Biotech Showcase 2024finance.yahoo.com - December 14 at 8:03 AMHumanity May Conquer Breast Cancer Soonmsn.com - December 12 at 1:44 PMBreast cancer killing vaccine that 'directs immune system to kill cancer cells' being tested in trialsmsn.com - December 12 at 1:17 PMNew vaccine being tested aims to destroy cancer cellsmsn.com - December 12 at 8:17 AMVaccine that 'directs immune system to kill breast cancer cells' being tested in trialsmsn.com - December 12 at 12:06 AMAnixa Biosciences: Strong Buy Rating Backed by Promising Phase 1 Cancer Vaccine and CAR-T Therapy Trialsmarkets.businessinsider.com - December 8 at 10:41 AMAn end to breast cancer? California company develops groundbreaking vaccine with promising futuremsn.com - December 8 at 5:41 AMAnixa and Cleveland Clinic report Phase I breast cancer vaccine datamsn.com - December 7 at 7:08 PMAnixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'msn.com - December 7 at 2:07 PM Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ANIX Media Mentions By Week ANIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIX News Sentiment▼0.610.61▲Average Medical News Sentiment ANIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIX Articles This Week▼82▲ANIX Articles Average Week Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cartesian Therapeutics News Eton Pharmaceuticals News Celularity News Assertio News DiaMedica Therapeutics News Spero Therapeutics News Vaccitech News Reviva Pharmaceuticals News Barinthus Biotherapeutics News Lantern Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIX) was last updated on 3/30/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsI tried to warn you Porter & CompanyTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill PublishingUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.